Statistical optimization of bambara groundnut protein isolate-alginate matrix systems on survival of encapsulated <em>Lactobacillus rhamnosus</em> GG

• Main Authors: Kanyanat Kaewiad, Nattha Kaewnopparat, Damrongsak Faroongsarng, Juraithip Wungsintaweekul, Sanae Kaewnopparat
• Format: Article
• Language: English
• Published: AIMS Press 2017-08-01
• Series: AIMS Microbiology
• Subjects: <em>Lactobacillus rhamnosus</em> GG; encapsulation; bambara groundnut protein isolate; gastrointestinal tract; storage
• Online Access: http://www.aimspress.com/microbiology/article/1576/fulltext.html

Encapsulation may protect viable probiotic cells. This study aims at the evaluation of a bambara groundnut protein isolate (BGPI)-alginate matrix designed for encapsulating a probiotic <em>Lactobacillus rhamnosus</em> GG. The response surface methodology was employed to gain the optimal concentrations of BGPI and alginate on encapsulation efficiency and survival of encapsulated cells. The capsules were prepared at the optimal combination by the traditional extrusion method composed of 8.66% w/v BGPI and 1.85% w/v alginate. The encapsulation efficiency was 97.24%, whereas the survival rates in an acidic condition and after the freeze-drying process were 95.56% and 95.20%, respectively—higher than those using either BGPI or alginate as the encapsulating agent individually. The designed capsules increased the probiotic <em>L. rhamnosus</em> GG survival relative to free cells in a simulated gastric fluid by 5.00 log cfu/ml after 3 h and in a simulated intestinal fluid by 8.06 log cfu/ml after 4 h. The shelf-life studies of the capsules over 6 months at 4 °C and 30 °C indicated that the remaining number of viable cells in a BGPI-alginate capsule was significantly higher than that of free cells in both temperatures. It was demonstrated that the BGPI-alginate capsule could be utilized as a new probiotic carrier for enhanced gastrointestinal transit and storage applied in food and/or pharmaceutical products.